{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:24:08Z","timestamp":1754396648585,"version":"3.41.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019871","name":"Castle Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jcjo.2024.09.004","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T02:35:39Z","timestamp":1727836539000},"page":"170-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic analysis of metastatic versus nonmetastatic conjunctival melanoma using a cutaneous melanoma gene expression panel"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5172-5779","authenticated-orcid":false,"given":"Jessica J.","family":"Waninger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Yesim","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2024.09.004_bib0001","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41467-020-20432-5","article-title":"Ultraviolet radiation drives mutations in a subset of mucosal melanomas","volume":"12","author":"Mundra","year":"2021","journal-title":"Nat. Commun"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0002","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1038\/s41467-019-11107-x","article-title":"Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets","volume":"10","author":"Newell","year":"2019","journal-title":"Nat. Commun"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0003","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/genes14091668","article-title":"Genetic aspects of conjunctival melanoma: a review","volume":"14","author":"Chang","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0004","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jamaophthalmol.2019.4237","article-title":"Integrative exome and transcriptome analysis of conjunctival melanoma and its potential application for personalized therapy","volume":"137","author":"Demirci","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0005","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3390\/cancers14133066","article-title":"GNAQ and GNA11 genes: a comprehensive review on oncogenesis, prognosis and therapeutic opportunities in uveal melanoma","volume":"14","author":"Silva-Rodr\u00edguez","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0006","article-title":"Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma","volume":"8","author":"Song","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","article-title":"Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma","volume":"21","author":"Gerami","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0008","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ophtha.2022.01.016","article-title":"Mutational landscape and outcomes of conjunctival melanoma in 101 patients","volume":"129","author":"Lally","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0009","doi-asserted-by":"crossref","first-page":"17 022","DOI":"10.1038\/s41598-020-72864-0","article-title":"Transcriptional characterization of conjunctival melanoma identifies the cellular tumor microenvironment and prognostic gene signatures","volume":"10","author":"Wolf","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/CMR.0000000000000686","article-title":"The molecular profile of mucosal melanoma","volume":"30","author":"Mikkelsen","year":"2020","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009201","article-title":"Genomic and transcriptomic landscape of conjunctival melanoma","volume":"16","author":"Cisarova","year":"2020","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0012","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/archopht.118.11.1497","article-title":"Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients","volume":"118","author":"Shields","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0013","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clindermatol.2023.10.010","article-title":"Conjunctival melanoma: Insights into classification, outcomes, and biomarkers","volume":"42","author":"Shields","year":"2024","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaophthalmol.2019.1640","article-title":"Multicenter, international assessment of the eighth edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma","volume":"137","author":"Jain","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0015","doi-asserted-by":"crossref","first-page":"eaal1953","DOI":"10.1126\/sciimmunol.aal1953","article-title":"Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes","volume":"3","author":"Arenzana","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0016","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","author":"Dey","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0017","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/cdd.2017.95","article-title":"Germline BAP1 mutations induce a Warburg effect","volume":"24","author":"Bononi","year":"2017","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0018","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.celrep.2016.05.096","article-title":"NeuCode proteomics reveals Bap1 regulation of metabolism","volume":"16","author":"Baughman","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0019","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41418-022-01024-w","article-title":"BAP1 promotes the repair of UV-induced DNA damage via PARP1-mediated recruitment to damage sites and control of activity and stability","volume":"29","author":"Lee","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.1309085110","article-title":"Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair","volume":"111","author":"Yu","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0021","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhng","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0022","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.aav4902","article-title":"Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1","volume":"364","author":"He","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0023","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0024","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0025","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1186\/s12885-018-5079-x","article-title":"Comparison of germline versus somatic BAP1 mutations for risk of metastasis in uveal melanoma","volume":"18","author":"Ewens","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0026","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/jnci\/95.14.1028","article-title":"Leukotriene A4 signaling, inflammation, and cancer","volume":"95","author":"DuBois","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0027","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/carcin\/bgx049","article-title":"LTA4H regulates cell cycle and skin carcinogenesis","volume":"38","author":"Oi","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0028","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0029","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/ijms18020236","article-title":"Cross-talk between cancer cells and the tumour microenvironment: the role of the 5-lipoxygenase pathway","volume":"18","author":"Moore","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0030","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/ni970","article-title":"Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment","volume":"4","author":"Tager","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0031","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/vaccines9020138","article-title":"Targeting innate immunity in cancer therapy","volume":"9","author":"Rameshbabu","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.680407","article-title":"Immunotherapy in acral and mucosal melanoma: current status and future directions","volume":"12","author":"Mao","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154968","article-title":"Blocking LTB4 signaling-mediated TAMs recruitment by Rhizoma Coptidis sensitizes lung cancer to immunotherapy","volume":"119","author":"Yan","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0034","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317709805","article-title":"Eukaryotic translation initiation factors and cancer","volume":"39","author":"Ali","year":"2017","journal-title":"Tumor Biol"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12964-020-00607-9","article-title":"Eukaryotic translation initiation factors as promising targets in cancer therapy","volume":"18","author":"Hao","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0036","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1167\/iovs.18-26508","article-title":"Conjunctival melanoma targeted therapy: MAPK and PI3K\/mTOR pathways inhibition","volume":"60","author":"Zaoui","year":"2019","journal-title":"Investig Opthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0037","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CMR.0b013e32832ccd09","article-title":"Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma","volume":"20","author":"P\u00f3pulo","year":"2010","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jcjo.2024.09.004_bib0038","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-1-62703-727-3_22","article-title":"Molecular diagnostics for melanoma, methods and protocols","volume":"1102","author":"Harbour","year":"2013","journal-title":"Methods Mol Biol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224002850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224002850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T03:58:38Z","timestamp":1750132718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418224002850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0008418224002850"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.09.004","relation":{},"ISSN":["0008-4182"],"issn-type":[{"type":"print","value":"0008-4182"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic analysis of metastatic versus nonmetastatic conjunctival melanoma using a cutaneous melanoma gene expression panel","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}